Etomidate and ketamine are both commonly used induction agents. Etomidate acts via GABA receptors at a dose of 0.3 mg/kg IV, with rapid onset similar to thiopental but less cardiovascular and respiratory depression. However, it can cause adrenal suppression. Ketamine is a dissociative agent that acts via NMDA antagonism at doses of 1-2 mg/kg IV, providing profound analgesia while maintaining airway reflexes and spontaneous breathing. It increases blood pressure, heart rate and intracranial pressure but is useful for bronchospasm. Both drugs can cause emergence phenomena.